Adaptive Treatment for Adolescent Cannabis Use Disorders

UConn Health172 enrolled

Overview

The purpose of this study is to examine an Adaptive Treatment approach in order to improve outcomes of youth with Cannabis Use Disorders who are poor responders to treatment.

The study will address the current contrasts in youth response to treatment, the problem of poor response to treatment and the prevention of relapse. Results from the study may support Adaptive Treatment as an efficacious approach for youth with Cannabis Use Disorder who are poor responders to treatment. Poor responders fall into two categories, those who failed to achieve a negative drug urinalysis during the last session of the initial MET/CBT-7 treatment they attended, and those who either dropped out or were administratively discharged at any time during the initial MET/CBT-7 treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

172

Conditions

Mental Disorders Addictive Behaviors Cannabis Use Disorder

Interventions

ACRABEHAVIORAL

Ten weekly,60-minute therapy sessions including six individual, two parent/guardian and two joint (individual and parent/guardian).

CBTBEHAVIORAL

10 weekly, 60-minute sessions of augmented individualized CBT

Eligibility

Sex: ALLMin age: 13 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 13-18 years of age at the time of intake assessment * Current diagnosis of DSM-IV Cannabis Abuse or Dependence * Able to read and comprehend English at a 5th grade level * Residence within 45 minutes drive from the UCHC Farmington treatment site * Participant and a parent/legal guardian responsible for providing collateral information agree to sign an IRB approved consent form * Participant and a parent/legal guardian responsible for providing collateral information agree to provide locator information * The family is not planning to move from the area during the next six months Exclusion Criteria: * Meet criteria for dependence of any other substance of abuse other than nicotine or alcohol * Report suicidal ideation with a plan, suicidal behavior, a plan to hurt oneself or other, or a history of self-injurious behavior all occurring in the last 30 days * Meet a lifetime diagnosis of schizophrenia * Has any current health (i.e. medical, psychiatric) condition that will compromise the participant's ability to regularly attend treatment * Demonstrate an inability or unwillingness to provide locator information

Locations (1)

University of Connecticut Health Center

Farmington, Connecticut, United States

Outcomes

Primary Outcomes

1.) To evaluate the efficacy of AT for youth who have been defined as poor responders to an evidence-based practice intervention such as the initial MET/CBT-7.

Each participant will serve as his/her own control. The outcomes will include the T-ASI, T-ASI-P, and drug urinalyses.

Time frame: one year

Secondary Outcomes

To assess outcomes as a function of mediator variables such as self-efficacy, coping skills, readiness to change, and environmental support (i.e., family and peer), within each of the AT interventions.

The secondary outcome measures will include the SCQ, CRI, PRQ, and SSQ.

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.